Correspondence

Retina. 2013 Nov-Dec;33(10):2185. doi: 10.1097/IAE.0b013e31829f731e.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Female
  • Humans
  • Male
  • Wet Macular Degeneration / drug therapy*

Substances

  • Adrenergic beta-Antagonists
  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized